JMP Securities analyst Jason Butler reiterated a Buy rating on Abivax SA Sponsored ADR (ABVX – Research Report) today and set a price target of ...
Every investor is in the markets to find a return, and there are as many investing strategies as there are investors. Some prefer to play ...
Hosted on MSN23h
JMP Securities Initiates Coverage of Context Therapeutics (CNTX) with Market Outperform RecommendationFintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback